Search Result "MDS/AML"


Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS

Journal: Current Cancer Drug Targets
Volume: 6 Issue: 6 Year: 2006 Page: 553-563
Author(s): Hironori Harada, Yuka Harada, Akiro Kimura

DNA Hypermethylation of Myeloid Cells, A Novel Therapeutic Target in MDS and AML

Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 315-321
Author(s): Claudia I. Muller, Bjorn Ruter, H. Phillip Koeffler, Michael Lubbert

Review Article

Targeting Immune Signaling Pathways in Clonal Hematopoiesis

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 28 Year: 2019 Page: 5262-5277
Author(s): Nessar Ahmad Azrakhsh,Patrycja Mensah-glanowska,Kristoffer Sand,Astrid Olsnes Kittang

Implication of microRNAs in the Pathogenesis of MDS

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3170-3179
Author(s): Jing Fang,Melinda Varney,Daniel T. Starczynowski

Optimizing Outcomes Following Allogeneic Hematopoietic Progenitor Cell Transplantation in AML: The Role of Hypomethylating Agents

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 6 Year: 2013 Page: 661-669
Author(s): Massimo Martino,Roberta Fedele,Tiziana Moscato,Francesca Ronco

Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 13 Year: 2012 Page: 1751-1754
Author(s): Matilde Y. Follo, Sara Mongiorgi, Carlo Finelli, Manuela Piazzi, Irene Faenza, Giulia Ramazzotti, Patrizia Santi, James A. McCubrey, Alberto M. Martelli, Lucio Cocco

Inhibition of Raf Kinase in the Treatment of Acute Myeloid Leukemia

Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2243-2248
Author(s): Michael Crump

Review Article

Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 1 Year: 2017 Page: 135-169
Author(s): Karmen Stankov,Suncica Stankov,Jasmina Katanic

Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2014 Page: 873-883
Author(s): Lucia Manzoli, Sara Mongiorgi, Cristina Clissa, Carlo Finelli, Anna Maria Billi, Alessandro Poli, Marilisa Quaranta, Lucio Cocco, Matilde Y. Follo

Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2349-2357
Author(s): Carlo Finelli, Matilde Y. Follo, Marta Stanzani, Sarah Parisi, Cristina Clissa, Sara Mongiorgi, Marilena Barraco, Lucio Cocco

Previous   Next

Go To   Results 1 - 1 of 792

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy